查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1454809

神经復健设备市场：依产品类型、最终用户、地区（北美、欧洲、亚太地区、拉丁美洲、中东非洲）、规模、占有率、成长、趋势、预测（2023-2030 年）进行的全球产业分析

Neurorehabilitation Devices Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 228 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究发布了对全球神经復健设备市场的全面分析。 这份富有洞察力的报告提供了关键市场动态、市场驱动因素、课题和新兴趋势的宝贵见解。 该报告详细概述了神经復健设备产业，并提供了独家数据和统计数据来预测 2023 年至 2030 年的市场成长轨迹。

全球神经復健设备市场预计复合年增长率为 12.7%，从 2023 年的 19 亿美元增长到 2030 年底的 46 亿美元。

关键见解

  • 神经復健设备市场规模（2023 年）：19 亿美元
  • 预计市场价值（2030 年）：46 亿美元
  • 全球市场成长率（2023-2030 年复合年增长率）：12.7%
  • 过去的市场成长率（2018-2022 年复合年增长率）：12.0%

神经復健设备市场-报告范围：

在神经系统疾病盛行率不断上升、復健服务需求不断增加以及医疗技术进步的推动下，神经復健设备市场预计将显着增长。 该市场为医院、復健中心、诊所和家庭护理机构提供服务，提供各种专为各种应用而设计的神经復健设备，包括行动辅助、肌肉强化和认知训练。 神经系统疾病患者对个人化復健计画、功能恢復和生活品质改善的需求推动了市场成长。

市场驱动因素：

全球神经復健设备市场受益于几个关键的成长促进因素。 中风、脊髓损伤和脑外伤等神经系统疾病负担的增加正在推动市场扩张。 机器人外骨骼、脑机介面、神经肌肉电刺激系统等神经復健设备为运动復健、感觉再教育和认知增强提供创新解决方案。 此外，神经影像技术、神经可塑性研究和个人化医疗的进步使得量身定制的干预措施和结果监测成为可能，从而改善患者的治疗结果和满意度。 此外，远距復健服务、远距患者监护和数位健康平台的日益普及也对市场产生了影响。

市场限制因素：

儘管成长前景广阔，但神经復健设备市场仍面临成本限制、报销政策和技术障碍等课题。 与神经復健设备相关的高昂初始投资和持续维护成本可能会限制其采用，特别是在资源有限的医疗保健环境中。 此外，復健服务和辅助设备的报销范围因地区而异，影响了市场准入和患者的负担能力。 此外，互通性问题、资料安全问题和监管合规性要求为技术整合和远端復健工作带来了课题。 解决这些障碍需要医疗保健提供者、付款人、技术供应商和监管机构共同努力开发可扩展且具有成本效益的解决方案，以改善获得神经復健服务的机会。

市场机会：

由于技术创新、以患者为中心的护理模式以及家庭復健计划的扩展，神经復健设备市场提供了巨大的成长机会。 穿戴式感测器、虚拟实境平台和行动应用程式的开发实现了远端监控、即时回馈和游戏化復健练习，以提高患者的参与度和治疗依从性。 此外，策略伙伴关係、与神经科学家和復健专家的合作以及对临床研究的投资将加速市场验证和采用。 此外，对使用者培训、护理人员支援和社区为基础的復健服务的重视将推动市场成长，并促进神经復健设备在快速发展的神经护理领域的使用。

本报告涵盖的主要问题

  • 全球神经復健设备市场的预期复合年增长率是多少？
  • 2023 年的市场规模有多大？
  • 2023 年哪个国家将占最大的市场占有率？
  • 谁是神经復健设备市场的主要参与者？
  • 依应用程式划分，成长最快的细分市场为何？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 作业
    • 主要趋势
  • 产品生命週期分析
  • 神经復健设备市场：价值链
    • 原料供应商名单
    • 製造商列表
    • 销售代理商名单
    • 申请列表
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：对市场的影响
  • 宏观经济因素
    • 世界产业展望
    • 世界 GDP 成长率的前景
    • 全球母公司市场概览
  • 预测因子 - 相关性和影响
  • 监管与科技环境

第三章全球神经復健设备市场展望：实际结果（2018-2022年）与预测（2023-2030年）

  • 主要亮点
    • 市场容量（单位）预测
    • 市场规模及年成长率
    • 绝对的获利机会
  • 市场规模（万美元）分析与预测
    • 过去的市场规模分析，2013-2016 年
    • 2018-2026 年目前市场规模预测
  • 全球神经復健设备市场展望：产品
    • 简介/主要发现
    • 2018-2022 年依产品划分的过往市场规模（百万美元）和数量（单位）分析
    • 目前市场规模（百万美元）和 2023-2030 年依产品划分的数量（单位）预测
      • 神经机器人系统
      • 脑机接口
      • 穿戴式装置
      • 脑刺激装置
  • 市场吸引力分析：产品
  • 全球神经復健设备市场展望：最终用户
    • 简介/主要发现
    • 2018-2022 年最终用户的过往市场规模（百万美元）和数量（单位）分析
    • 2023-2030 年最终用户的当前市场规模（百万美元）和预测销售（单位）
      • 復健中心
      • 医院和诊所
      • 居家护理
      • 其他
  • 市场吸引力分析：最终用户
  • 全球神经復健设备市场展望：应用
    • 简介/主要发现
    • 2018-2022 年依应用划分的过往市场规模（10,000 美元）和数量（单位）分析
    • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
      • 中风
      • 帕金森氏症
      • 脑部和脊髓损伤
      • 脑性麻痹
      • 多发性硬化症
      • 其他
  • 市场吸引力分析：应用

第 4 章全球神经復健设备市场展望：地区

  • 主要亮点
  • 2018-2022 年依地区历史市场规模（百万美元）及销售量（单位）分析
  • 2023-2030 年依地区划分的当前市场规模（百万美元）和预测销售（单位）
    • 北美
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲 (MEA)
  • 市场吸引力分析：地区

第五章北美神经復健设备市场展望：实际结果（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和市场销售（单位）分析
    • 依国家/地区
    • 依产品
    • 依最终用户
    • 依用途
  • 2023-2030 年依国家/地区划分的当前市场规模（百万美元）和销售（单位）预测
    • 美国
    • 加拿大
  • 目前市场规模（百万美元）和 2023-2030 年依产品划分的数量（单位）预测
    • 神经机器人系统
    • 脑机接口
    • 穿戴式装置
    • 脑刺激装置
  • 2023-2030 年最终用户的当前市场规模（百万美元）和预测销售（单位）
    • 復健中心
    • 医院和诊所
    • 居家护理
    • 其他
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 中风
    • 帕金森氏症
    • 脑部和脊髓损伤
    • 脑性麻痹
    • 多发性硬化症
    • 其他
  • 市场吸引力分析

第六章欧洲神经復健设备市场展望：实际结果（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和市场销售（单位）分析
    • 依国家/地区
    • 依产品
    • 依最终用户
    • 依用途
  • 2023-2030 年依国家/地区划分的当前市场规模（百万美元）和销售（单位）预测
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 土耳其
    • 欧洲其他地区
  • 目前市场规模（百万美元）和 2023-2030 年依产品划分的数量（单位）预测
    • 神经机器人系统
    • 脑机接口
    • 穿戴式装置
    • 脑刺激装置
  • 2023-2030 年最终用户的当前市场规模（百万美元）和预测销售（单位）
    • 復健中心
    • 医院和诊所
    • 居家护理
    • 其他
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 中风
    • 帕金森氏症
    • 脑部和脊髓损伤
    • 脑性麻痹
    • 多发性硬化症
    • 那个其他
  • 市场吸引力分析

第七章东亚神经復健设备市场展望：实际（2018-2022）与预测（2023-2030）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和市场销售（单位）分析
    • 依国家/地区
    • 依产品
    • 依最终用户
    • 依用途
  • 2023-2030 年依国家/地区划分的当前市场规模（百万美元）和销售（单位）预测
    • 中国
    • 日本
    • 韩国
  • 目前市场规模（百万美元）和 2023-2030 年依产品划分的数量（单位）预测
    • 神经机器人系统
    • 脑机接口
    • 穿戴式装置
    • 脑刺激装置
  • 2023-2030 年最终用户的当前市场规模（百万美元）和预测销售（单位）
    • 復健中心
    • 医院和诊所
    • 居家护理
    • 其他
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 中风
    • 帕金森氏症
    • 脑部和脊髓损伤
    • 脑性麻痹
    • 多发性硬化症
    • 其他
  • 市场吸引力分析

第8章南亚与大洋洲神经復健设备市场展望：实际（2018-2022年）与预测（2023-2030年）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和市场销售（单位）分析
    • 依国家/地区
    • 依产品
    • 依最终用户
    • 依用途
  • 2023-2030 年依国家/地区划分的当前市场规模（百万美元）和销售（单位）预测
    • 印度
    • 东南亚
    • 纽西兰
    • 南亚和大洋洲其他地区
  • 目前市场规模（百万美元）和 2023-2030 年依产品划分的数量（单位）预测
    • 神经机器人系统
    • 脑机接口
    • 穿戴式装置
    • 脑刺激装置
  • 2023-2030 年最终用户的当前市场规模（百万美元）和预测销售（单位）
    • 復健中心
    • 医院和诊所
    • 居家护理
    • 其他
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 中风
    • 帕金森氏症
    • 脑部和脊髓损伤
    • 脑性麻痹
    • 多发性硬化症
    • 其他
  • 市场吸引力分析

第9章拉丁美洲神经復健设备市场展望：实际（2018-2022年）与预测（2023-2030年）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和市场销售（单位）分析
    • 依国家/地区
    • 依产品
    • 依最终用户
    • 依用途
  • 2023-2030 年依国家/地区划分的当前市场规模（百万美元）和销售（单位）预测
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 目前市场规模（百万美元）和 2023-2030 年依产品划分的数量（单位）预测
    • 神经机器人系统
    • 脑机接口
    • 穿戴式装置
    • 脑刺激装置
  • 2023-2030 年最终用户的当前市场规模（百万美元）和预测销售（单位）
    • 復健中心
    • 医院和诊所
    • 居家护理
    • 其他
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 中风
    • 帕金森氏症
    • 脑部和脊髓损伤
    • 脑性麻痹
    • 多发性硬化症
    • 其他
  • 市场吸引力分析

第10章中东与非洲神经復健设备市场展望：实际（2018-2022年）与预测（2023-2030年）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和市场销售（单位）分析
    • 依国家/地区
    • 依产品
    • 依最终用户
    • 依用途
  • 2023-2030 年依国家/地区划分的当前市场规模（百万美元）和销售（单位）预测
    • 海湾合作委员会
    • 埃及
    • 南非
    • 北非
    • 其他中东和非洲地区
  • 目前市场规模（百万美元）和 2023-2030 年依产品划分的数量（单位）预测
    • 神经机器人系统
    • 脑机接口
    • 穿戴式装置
    • 脑刺激装置
  • 2023-2030 年最终用户的当前市场规模（百万美元）和预测销售（单位）
    • 復健中心
    • 医院和诊所
    • 居家护理
    • 其他
  • 2023-2030 年当前市场规模（百万美元）和依应用划分的数量（单位）预测
    • 中风
    • 帕金森氏症
    • 脑部和脊髓损伤
    • 脑性麻痹
    • 多发性硬化症
    • 其他
  • 市场吸引力分析

第十一章竞争态势

  • 2022 年市占率分析
  • 市场结构
    • 依市场划分的竞争强度图
    • 有竞争力的类比 IC
    • 表观产品产能
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Neofect
    • Boston Scientific Corporation
    • AlterG Inc.
    • Eodyne
    • Medtronic plc
    • Biometrics Ltd.
    • Bioness Inc.
    • Kinestica
    • Hocoma AG
    • BIONIK Laboratories Corp.
    • Ekso Bionics Holdings Inc.

第12章附录

  • 调查方法
  • 调查假设
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP33993

Persistence Market Research, a leading market research firm, has recently conducted a comprehensive analysis of the global Neurorehabilitation Devices Market. This insightful report offers valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. The report provides a detailed overview of the neurorehabilitation devices industry, featuring exclusive data and statistics projecting the market's growth trajectory from 2023 to 2030.

The global neurorehabilitation devices market is forecast to expand at a CAGR of 12.7% and thereby increase from US$1.9 Bn in 2023, to US$4.6 Bn by the end of 2030.

Key Insights:

  • Neurorehabilitation Devices Market Size (2023): US$1.9 Bn
  • Projected Market Value (2030): US$4.6 Bn
  • Global Market Growth Rate (CAGR 2023 to 2030): 12.7%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 12.0%

Neurorehabilitation Devices Market - Report Scope:

The Neurorehabilitation Devices Market is poised for significant growth, driven by the increasing prevalence of neurological disorders, the rising demand for rehabilitation services, and advancements in medical technology. This market serves hospitals, rehabilitation centers, clinics, and homecare settings, offering a range of neurorehabilitation devices designed for various applications, including mobility assistance, muscle strengthening, and cognitive training. Market growth is fueled by the need for personalized rehabilitation programs, functional recovery, and improved quality of life for patients with neurological impairments.

Market Growth Drivers:

The global Neurorehabilitation Devices Market benefits from several key growth drivers. The growing burden of neurological conditions, such as stroke, spinal cord injury, and traumatic brain injury, drives market expansion. Neurorehabilitation devices, such as robotic exoskeletons, brain-computer interfaces, and neuromuscular electrical stimulation systems, offer innovative solutions for motor rehabilitation, sensory retraining, and cognitive enhancement. Moreover, advancements in neuroimaging techniques, neuroplasticity research, and personalized medicine enable tailored interventions and outcome monitoring, enhancing patient outcomes and satisfaction. The market is also influenced by the increasing adoption of tele-rehabilitation services, remote patient monitoring, and digital health platforms.

Market Restraints:

Despite promising growth prospects, the Neurorehabilitation Devices Market faces challenges related to cost constraints, reimbursement policies, and technological barriers. The high upfront investment and ongoing maintenance costs associated with neurorehabilitation devices may limit adoption, particularly in resource-constrained healthcare settings. Additionally, reimbursement coverage for rehabilitation services and assistive devices varies across regions, impacting market access and affordability for patients. Furthermore, interoperability issues, data security concerns, and regulatory compliance requirements pose challenges for technology integration and tele-rehabilitation initiatives. Addressing these barriers requires collaboration between healthcare providers, payers, technology vendors, and regulatory agencies to develop scalable and cost-effective solutions that improve access to neurorehabilitation services.

Market Opportunities:

The Neurorehabilitation Devices Market presents significant growth opportunities driven by technological innovations, patient-centric care models, and the expansion of home-based rehabilitation programs. The development of wearable sensors, virtual reality platforms, and mobile applications enables remote monitoring, real-time feedback, and gamified rehabilitation exercises, enhancing patient engagement and adherence to therapy. Furthermore, strategic partnerships, collaborations with neuroscientists and rehabilitation specialists, and investment in clinical research facilitate market validation and adoption. Moreover, emphasis on user training, caregiver support, and community-based rehabilitation services fosters market growth and advances the use of neurorehabilitation devices in the rapidly evolving landscape of neurological care.

Key Questions Answered in the Report:

  • What is the Forecast CAGR of the Global Neurorehabilitation Devices Market?
  • What was the Market Size in the Year 2023?
  • Which Country Held the Largest Market Share in 2023?
  • Who are the Major Players in the Neurorehabilitation Devices Market?
  • Which is the Fastest-growing Market Segment by Application?

Competitive Intelligence and Business Strategy:

In the neurorehabilitation devices industry, key players like Bioness Inc., Ekso Bionics Holdings, Inc., and Medtronic plc maintain their dominance through a relentless focus on innovation. These companies continuously invest in research and development to advance their products, with Medtronic specializing in neurostimulation technologies, Ekso Bionics enhancing robotic exoskeletons, and Bioness leading in neuromodulation devices.

Strategic partnerships are another cornerstone of their market strategy. By collaborating with rehabilitation centers, healthcare providers, and research institutions, these entities effectively integrate their devices into clinical practice. Bioness, for example, partners with renowned rehabilitation centers to ensure the seamless adoption of its neuromodulation devices into standard patient treatment protocols.

Furthermore, these industry leaders prioritize expanding their international presence to maximize market share. Medtronic, in particular, ensures global accessibility of its neurorehabilitation devices through an extensive network, catering to critical markets worldwide. This proactive approach to partnerships and global outreach solidifies their market dominance and reinforces their position as leaders in neurorehabilitation technology.

Key Companies Profiled:

  • Neofect
  • Boston Scientific Corporation
  • AlterG Inc.
  • Eodyne
  • Medtronic plc
  • Biometrics Ltd.
  • Bioness Inc.
  • Kinestica
  • Hocoma AG
  • BIONIK Laboratories Corp.
  • Ekso Bionics Holdings Inc.

Neurorehabilitation Devices Market Research Segmentation:

Neurorobotic systems are poised to dominate the neurorehabilitation devices market, offering comprehensive solutions for motor skill restoration through advanced robotic technologies. Their adaptability and customization capabilities make them a preferred choice, with Brain Computer Interface (BCI) technology emerging as the fastest-growing segment due to its direct communication with the brain for precise feedback and control during rehabilitation processes.

In terms of application, stroke rehabilitation solutions are expected to lead the market, addressing the prevalent demand for effective recovery methods post-stroke. Additionally, Parkinson's disease rehabilitation is forecasted to witness significant growth, driven by the increasing incidence of Parkinson's and advancements in targeted interventions like brain stimulators and neurorobotic systems tailored for Parkinson's patients.

North America is positioned as the dominant regional market, propelled by rigorous R&D efforts, a robust healthcare infrastructure, and favorable reimbursement policies. The region's proactive approach to integrating advanced medical devices and its concentration of major industry players contribute to its leadership in neurorehabilitation device adoption. Meanwhile, the South Asia and Pacific region is expected to experience rapid expansion due to its growing geriatric population, rising neurological disorder prevalence, and increasing healthcare investments, presenting significant opportunities for neurorehabilitation device manufacturers amidst a dynamic healthcare landscape.

By Product:

  • Neurorobotic Systems
  • Brain-Computer Interface
  • Wearable Devices
  • Brain Stimulators

By Application:

  • Stroke
  • Parkinson's Disease
  • Brain & Spinal Cord Injury
  • Cerebral Palsy
  • Multiple Sclerosis
  • Others

By End User:

  • Rehabilitation Centers
  • Hospitals & Clinics
  • Home Care
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Neurorehabilitation Devices Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Lifecycle Analysis
  • 2.4. Neurorehabilitation Devices Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global Neurorehabilitation Devices Market Outlook: Product
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
      • 3.3.3.1. Neurorobotic Systems
      • 3.3.3.2. Brain Computer Interface
      • 3.3.3.3. Wearable Devices
      • 3.3.3.4. Brain Stimulators
  • 3.4. Market Attractiveness Analysis: Product
  • 3.5. Global Neurorehabilitation Devices Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.5.3.1. Rehabilitation Centers
      • 3.5.3.2. Hospitals & Clinics
      • 3.5.3.3. Home Care
      • 3.5.3.4. Others
  • 3.6. Market Attractiveness Analysis: End User
  • 3.7. Global Neurorehabilitation Devices Market Outlook: Application
    • 3.7.1. Introduction / Key Findings
    • 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
    • 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
      • 3.7.3.1. Stroke
      • 3.7.3.2. Parkinson's Disease
      • 3.7.3.3. Brain & Spinal Cord Injury
      • 3.7.3.4. Cerebral Palsy
      • 3.7.3.5. Multiple Sclerosis
      • 3.7.3.6. Others
  • 3.8. Market Attractiveness Analysis: Application

4. Global Neurorehabilitation Devices Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia and Oceania
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product
    • 5.3.3. By End User
    • 5.3.4. By Application
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 5.5.1. Neurorobotic Systems
    • 5.5.2. Brain Computer Interface
    • 5.5.3. Wearable Devices
    • 5.5.4. Brain Stimulators
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.6.1. Rehabilitation Centers
    • 5.6.2. Hospitals & Clinics
    • 5.6.3. Home Care
    • 5.6.4. Others
  • 5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 5.7.1. Stroke
    • 5.7.2. Parkinson's Disease
    • 5.7.3. Brain & Spinal Cord Injury
    • 5.7.4. Cerebral Palsy
    • 5.7.5. Multiple Sclerosis
    • 5.7.6. Others
  • 5.8. Market Attractiveness Analysis

6. Europe Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product
    • 6.3.3. By End User
    • 6.3.4. By Application
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkiye
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 6.5.1. Neurorobotic Systems
    • 6.5.2. Brain Computer Interface
    • 6.5.3. Wearable Devices
    • 6.5.4. Brain Stimulators
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.6.1. Rehabilitation Centers
    • 6.6.2. Hospitals & Clinics
    • 6.6.3. Home Care
    • 6.6.4. Others
  • 6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 6.7.1. Stroke
    • 6.7.2. Parkinson's Disease
    • 6.7.3. Brain & Spinal Cord Injury
    • 6.7.4. Cerebral Palsy
    • 6.7.5. Multiple Sclerosis
    • 6.7.6. Others
  • 6.8. Market Attractiveness Analysis

7. East Asia Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product
    • 7.3.3. By End User
    • 7.3.4. By Application
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 7.5.1. Neurorobotic Systems
    • 7.5.2. Brain Computer Interface
    • 7.5.3. Wearable Devices
    • 7.5.4. Brain Stimulators
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.6.1. Rehabilitation Centers
    • 7.6.2. Hospitals & Clinics
    • 7.6.3. Home Care
    • 7.6.4. Others
  • 7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 7.7.1. Stroke
    • 7.7.2. Parkinson's Disease
    • 7.7.3. Brain & Spinal Cord Injury
    • 7.7.4. Cerebral Palsy
    • 7.7.5. Multiple Sclerosis
    • 7.7.6. Others
  • 7.8. Market Attractiveness Analysis

8. South Asia & Oceania Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product
    • 8.3.3. By End User
    • 8.3.4. By Application
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 8.5.1. Neurorobotic Systems
    • 8.5.2. Brain Computer Interface
    • 8.5.3. Wearable Devices
    • 8.5.4. Brain Stimulators
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.6.1. Rehabilitation Centers
    • 8.6.2. Hospitals & Clinics
    • 8.6.3. Home Care
    • 8.6.4. Others
  • 8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 8.7.1. Stroke
    • 8.7.2. Parkinson's Disease
    • 8.7.3. Brain & Spinal Cord Injury
    • 8.7.4. Cerebral Palsy
    • 8.7.5. Multiple Sclerosis
    • 8.7.6. Others
  • 8.8. Market Attractiveness Analysis

9. Latin America Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product
    • 9.3.3. By End User
    • 9.3.4. By Application
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 9.5.1. Neurorobotic Systems
    • 9.5.2. Brain Computer Interface
    • 9.5.3. Wearable Devices
    • 9.5.4. Brain Stimulators
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.6.1. Rehabilitation Centers
    • 9.6.2. Hospitals & Clinics
    • 9.6.3. Home Care
    • 9.6.4. Others
  • 9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 9.7.1. Stroke
    • 9.7.2. Parkinson's Disease
    • 9.7.3. Brain & Spinal Cord Injury
    • 9.7.4. Cerebral Palsy
    • 9.7.5. Multiple Sclerosis
    • 9.7.6. Others
  • 9.8. Market Attractiveness Analysis

10. Middle East & Africa Neurorehabilitation Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product
    • 10.3.3. By End User
    • 10.3.4. By Application
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
    • 10.5.1. Neurorobotic Systems
    • 10.5.2. Brain Computer Interface
    • 10.5.3. Wearable Devices
    • 10.5.4. Brain Stimulators
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.6.1. Rehabilitation Centers
    • 10.6.2. Hospitals & Clinics
    • 10.6.3. Home Care
    • 10.6.4. Others
  • 10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 10.7.1. Stroke
    • 10.7.2. Parkinson's Disease
    • 10.7.3. Brain & Spinal Cord Injury
    • 10.7.4. Cerebral Palsy
    • 10.7.5. Multiple Sclerosis
    • 10.7.6. Others
  • 10.8. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Analog IC
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Neofect
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Boston Scientific Corporation
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. AlterG Inc.
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Eodyne
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. Medtronic plc
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. Biometrics Ltd.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. Bioness Inc.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Kinestica
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. Hocoma AG
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. BIONIK Laboratories Corp.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy
    • 11.3.11. Ekso Bionics Holdings Inc.
      • 11.3.11.1. Overview
      • 11.3.11.2. Segments and Product
      • 11.3.11.3. Key Financials
      • 11.3.11.4. Market Developments
      • 11.3.11.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations